Not yet treated
-
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Phase 2 · randomised · 120 people · 33 sites in 6 countries · Recruiting now
-
A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 2 · randomised · 90 people · 3 sites in Germany · Recruiting now
-
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Phase 2 · randomised · 482 people · 14 sites in 5 countries · Recruiting now